20 May 2013
Keywords: pharming, prodarsan, completes, ph, trial, dutch, biotechnology
Article | 01 December 2008
Dutch biotechnology firm Pharming Group NV says that its wholly-owned subsidiary DNage has successfully completed a Phase I trial in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 December 2008
17 May 2013
© 2013 thepharmaletter.com